Literature DB >> 23385855

Refractory congestive heart failure following delayed pericardectomy in a 12-year-old child with Mulibrey nanism due to a novel mutation in TRIM37.

Matthias Kumpf1, Riikka H Hämäläinen, Michael Hofbeck, Winfried Baden.   

Abstract

UNLABELLED: Mulibrey nanism (MUL) is a rare autosomal recessive disorder with severe primordial growth retardation and multiorgan involvement, caused by mutations in TRIM37. Early clinical detection is important since more than 50 % of the patients develop congestive heart failure. We report a 12-year-old patient who presented in infancy with severe growth retardation, dysmorphic features, and cleft palate. Clinical diagnosis of MUL was established at the age of 5 years. Postmortem, molecular diagnostic confirmed MUL as a novel 1-bp deletion (c.1233delA) in exon 14 of the TRIM37 coding region. Cardiac examination at the age of 6 years revealed constrictive pericarditis with significant elevation of atrial filling pressures, consecutive hepatomegaly, and protein loosing enteropathy. Since the parents refused pericardectomy, surgery was delayed until the age of 12 years, when congestive heart failure deteriorated. Despite pericardectomy, the boy died from persistent right heart failure.
CONCLUSION: Our report underlines the necessity of early clinical diagnosis of Mulibrey nanism. Careful cardiologic examination is required to detect constrictive pericarditis, which is a major factor of mortality in these patients. Pericardectomy should be performed early, to avoid sequelae of persisting congestive heart failure.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23385855     DOI: 10.1007/s00431-013-1962-2

Source DB:  PubMed          Journal:  Eur J Pediatr        ISSN: 0340-6199            Impact factor:   3.183


  13 in total

1.  Gene encoding a new RING-B-box-Coiled-coil protein is mutated in mulibrey nanism.

Authors:  K Avela; M Lipsanen-Nyman; N Idänheimo; E Seemanová; S Rosengren; T P Mäkelä; J Perheentupa; A D Chapelle; A E Lehesjoki
Journal:  Nat Genet       Date:  2000-07       Impact factor: 38.330

Review 2.  Exploring the spectrum of 3-M syndrome, a primordial short stature disorder of disrupted ubiquitination.

Authors:  Peter E Clayton; Dan Hanson; Lucia Magee; Philip G Murray; Emma Saunders; Sayeda N Abu-Amero; Gudrun E Moore; Graeme C M Black
Journal:  Clin Endocrinol (Oxf)       Date:  2012-09       Impact factor: 3.478

3.  Physical growth of Swiss children from birth to 20 years of age. First Zurich longitudinal study of growth and development.

Authors:  A Prader; R H Largo; L Molinari; C Issler
Journal:  Helv Paediatr Acta Suppl       Date:  1989-06

4.  Cardiac dysfunction in children with mulibrey nanism.

Authors:  A Eerola; J I Pihkala; N Karlberg; M Lipsanen-Nyman; E Jokinen
Journal:  Pediatr Cardiol       Date:  2007-03-20       Impact factor: 1.655

5.  The TRIM37 gene encodes a peroxisomal RING-B-box-coiled-coil protein: classification of mulibrey nanism as a new peroxisomal disorder.

Authors:  Jukka Kallijärvi; Kristiina Avela; Marita Lipsanen-Nyman; Ismo Ulmanen; Anna-Elina Lehesjoki
Journal:  Am J Hum Genet       Date:  2002-04-05       Impact factor: 11.025

6.  Growth and symptoms in Silver-Russell syndrome: review on the basis of 386 patients.

Authors:  H A Wollmann; T Kirchner; H Enders; M A Preece; M B Ranke
Journal:  Eur J Pediatr       Date:  1995-12       Impact factor: 3.183

7.  Mulibrey heart disease: clinical manifestations, long-term course, and results of pericardiectomy in a series of 49 patients born before 1985.

Authors:  Marita Lipsanen-Nyman; Jaakko Perheentupa; Juhani Rapola; Anssi Sovijärvi; Markku Kupari
Journal:  Circulation       Date:  2003-05-19       Impact factor: 29.690

8.  Mulibrey nanism: clinical features and diagnostic criteria.

Authors:  N Karlberg; H Jalanko; J Perheentupa; M Lipsanen-Nyman
Journal:  J Med Genet       Date:  2004-02       Impact factor: 6.318

9.  High frequency of tumours in Mulibrey nanism.

Authors:  Niklas Karlberg; Susann Karlberg; Riitta Karikoski; Sakari Mikkola; Marita Lipsanen-Nyman; Hannu Jalanko
Journal:  J Pathol       Date:  2009-06       Impact factor: 7.996

10.  Growth and growth hormone therapy in subjects with mulibrey nanism.

Authors:  Niklas Karlberg; Hannu Jalanko; Marita Lipsanen-Nyman
Journal:  Pediatrics       Date:  2007-06-04       Impact factor: 7.124

View more
  5 in total

1.  TRIM37 promotes tumor cell proliferation and drug resistance in pediatric osteosarcoma.

Authors:  Yanling Tao; Meiyun Xin; Huanchen Cheng; Zongxuan Huang; Tiantian Hu; Teng Zhang; Jianlong Wang
Journal:  Oncol Lett       Date:  2017-09-26       Impact factor: 2.967

2.  Pericardial Constriction and Myocardial Restriction in Pediatric Mulibrey Nanism: A Complex Disease With Diastolic Dysfunction.

Authors:  Taisto Sarkola; Marita Lipsanen-Nyman; Hannu Jalanko; Eero Jokinen
Journal:  CJC Open       Date:  2021-08-30

Review 3.  Cardiomyopathies in Children and Systemic Disorders When Is It Useful to Look beyond the Heart?

Authors:  Valentina Lodato; Giovanni Parlapiano; Federica Calì; Massimo Stefano Silvetti; Rachele Adorisio; Michela Armando; May El Hachem; Antonino Romanzo; Carlo Dionisi-Vici; Maria Cristina Digilio; Antonio Novelli; Fabrizio Drago; Massimiliano Raponi; Anwar Baban
Journal:  J Cardiovasc Dev Dis       Date:  2022-01-31

4.  Transcriptomics unravels molecular players shaping dorsal lip hypertrophy in the vacuum cleaner cichlid, Gnathochromis permaxillaris.

Authors:  Laurène Alicia Lecaudey; Pooja Singh; Christian Sturmbauer; Anna Duenser; Wolfgang Gessl; Ehsan Pashay Ahi
Journal:  BMC Genomics       Date:  2021-07-05       Impact factor: 3.969

5.  Trim37-deficient mice recapitulate several features of the multi-organ disorder Mulibrey nanism.

Authors:  Kaisa M Kettunen; Riitta Karikoski; Riikka H Hämäläinen; Teija T Toivonen; Vasily D Antonenkov; Natalia Kulesskaya; Vootele Voikar; Maarit Hölttä-Vuori; Elina Ikonen; Kirsi Sainio; Anu Jalanko; Susann Karlberg; Niklas Karlberg; Marita Lipsanen-Nyman; Jorma Toppari; Matti Jauhiainen; J Kalervo Hiltunen; Hannu Jalanko; Anna-Elina Lehesjoki
Journal:  Biol Open       Date:  2016-05-15       Impact factor: 2.422

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.